Related references
Note: Only part of the references are listed.Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action
Jonathan Jia Yuan Ong et al.
NEUROTHERAPEUTICS (2018)
ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
David W. Dodick et al.
CEPHALALGIA (2018)
Calcitonin-gene-related peptide pathway mAbs and migraine prevention
Koen Paemeleire et al.
CURRENT OPINION IN NEUROLOGY (2018)
Vascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX
Majid Sheykhzade et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina
Christophe Depre et al.
HEADACHE (2018)
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine A Randomized Clinical Trial
David W. Dodick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
The big CGRP flood - sources, sinks and signalling sites in the trigeminovascular system
Karl Messlinger
JOURNAL OF HEADACHE AND PAIN (2018)
Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists
Jason M. Booe et al.
MOLECULAR PHARMACOLOGY (2018)
The Biology of Monoclonal Antibodies: Focus on Calcitonin Gene-Related Peptide for Prophylactic Migraine Therapy
Bianca Raffaelli et al.
NEUROTHERAPEUTICS (2018)
Evaluation of Galcanezumab for the Prevention of Episodic Migraine The EVOLVE-1 Randomized Clinical Trial
Virginia L. Stauffer et al.
JAMA NEUROLOGY (2018)
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Debbie L. Hay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
TRPA1 and TRPV1 are required for lidocaine-evoked calcium influx and neuropeptide release but not cytotoxicity in mouse sensory neurons
Mirjam Eberhardt et al.
PLOS ONE (2017)
A Novel α-Calcitonin Gene-Related Peptide Analogue Protects Against End-Organ Damage in Experimental Hypertension, Cardiac Hypertrophy, and Heart Failure
Aisah A. Aubdool et al.
CIRCULATION (2017)
Exploring the Role of TRPV and CGRP in Adenosine Preconditioning and Remote Hind Limb Preconditioning-Induced Cardioprotection in Rats
Amritpal Singh et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
TRPA1 activation leads to neurogenic vasodilatation: involvement of reactive oxygen nitrogen species in addition to CGRP and NO
Aisah A. Aubdool et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Long acting analogue of the calcitonin gene-related peptide induces positive metabolic effects and secretion of the glucagon-like peptide-1
Cecilia Nilsson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2016)
Receptor Activity-modifying Protein-directed G Protein Signaling Specificity for the Calcitonin Gene-related Peptide Family of Receptors
Cathryn Weston et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Intracellular TRPA1 mediates Ca2+ release from lysosomes in dorsal root ganglion neurons
Shujiang Shang et al.
JOURNAL OF CELL BIOLOGY (2016)
TRPA1 channels: molecular sentinels of cellular stress and tissue damage
Felix Viana
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Interaction of calcitonin gene related peptide (CGRP) and substance P (SP) in human skin
Tanja Schlereth et al.
NEUROPEPTIDES (2016)
Wiping Out CGRP: Potential Cardiovascular Risks
Antoinette MaassenVanDenBrink et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
TRPV1 activation is involved in the cardioprotection of remote limb ischemic postconditioning in ischemia-reperfusion injury rats
Yuanfeng Gao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine
Eva Cernuda-Morollon et al.
PAIN (2015)
Activation of transient receptor potential ankyrin 1 induces CGRP release from spinal cord synaptosomes
Talisia Quallo et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2015)
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
An Ongoing Role of α-Calcitonin Gene-Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress
Sarah-Jane Smillie et al.
HYPERTENSION (2014)
Calcitonin gene-related peptide (CGRP) in autonomic cardiovascular regulation and vascular structure
Tu H. Mai et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
Migraine and the Risk for Stroke and Cardiovascular Disease
Simona Sacco et al.
CURRENT CARDIOLOGY REPORTS (2014)
Investigating the potential role of TRPA1 in locomotion and cardiovascular control during hypertension
Jennifer V. Bodkin et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2014)
Inotropic and lusitropic effects of calcitonin gene-related peptide in the heart
Mustafa Al-Rubaiee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Role of CGRP-Receptor Component Protein (RCP) in CLR/RAMP Function
Ian M. Dickerson
CURRENT PROTEIN & PEPTIDE SCIENCE (2013)
A Role for TRPV1 in Influencing the Onset of Cardiovascular Disease in Obesity
Nichola J. Marshall et al.
HYPERTENSION (2013)
Alpha-calcitonin gene-related peptide is protective against pressure overload-induced heart failure
Jianping Li et al.
REGULATORY PEPTIDES (2013)
Therapeutic effects and safety of olcegepant and telcagepant for migraine A meta-analysis
Gang Yao et al.
NEURAL REGENERATION RESEARCH (2013)
G-protein βγ subunits in vasorelaxing and anti-endothelinergic effects of calcitonin gene-related peptide
M. J. P. M. T. Meens et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
The role of transient receptor potential ankyrin 1 (TRPA1) receptor activation in hydrogen-sulphide-induced CGRP-release and vasodilation
Gabor Pozsgai et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Calcitonin gene-related peptide facilitates revascularization during hindlimb ischemia in mice
Toshiaki Mishima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Calcitonin gene-related peptide (CGRP) and its role in hypertension
Sarah-Jane Smillie et al.
NEUROPEPTIDES (2011)
Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors
Tao Qi et al.
PEPTIDES (2011)
Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion
Zhen Liu et al.
REGULATORY PEPTIDES (2011)
Reversal of isoprenaline-induced cardiac remodeling by rutaecarpine via stimulation of calcitonin gene-related peptide production
Jian-Zhe Li et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
Pretreatment With Calcitonin Gene-Related Peptide Attenuates Hepatic Ischemia/Reperfusion Injury in Rats
S. W. Song et al.
TRANSPLANTATION PROCEEDINGS (2009)
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
J. Zeller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin:: Evaluation of a human in vivo pharmacodynamic model
B. J. Van der Schueren et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Effect of two novel CGRP-binding compounds in a closed cranial window rat model
Louise Juhl et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Functions of the cytoplasmic tails of the human receptor activity-modifying protein components of calcitonin gene-related peptide and adrenomedullin receptors
K Kuwasako et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with Aδ/C-fibers and colocalization with trk receptors
K Kobayashi et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2005)
Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model
A Bánvölgyi et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Increased circulating calcitonin gene-related peptide in congestive heart failure caused-by congenital heart disease
JH Hsu et al.
INTERNATIONAL HEART JOURNAL (2005)
Calcitonin gene related peptide mediates cardioprotection by remote preconditioning
S Wolfrum et al.
REGULATORY PEPTIDES (2005)
Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure
T Katori et al.
CIRCULATION RESEARCH (2005)
Calcitonin gene-related peptide and hypertension
PY Deng et al.
PEPTIDES (2005)
Development of angiotensin II-induced hypertension: role of CGRP and its receptor
JP Li et al.
JOURNAL OF HYPERTENSION (2005)
Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin
M Bandell et al.
NEURON (2004)
Calcitonin gene-related peptide receptor antagonist BIBN4096BS for the acute treatment of migraine
J Olesen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes
P Linscheid et al.
CRITICAL CARE MEDICINE (2004)
Role of calcitonin gene-related peptide in the phenol-induced neurogenic hypertension in rats
PY Deng et al.
REGULATORY PEPTIDES (2004)
Vascular actions of calcitonin gene-related peptide and adrenomedullin
SD Brain et al.
PHYSIOLOGICAL REVIEWS (2004)
Activation of the renin-angiotensin system in α-calcitonin gene-related peptide/calcitonin gene knockout mice
JP Li et al.
JOURNAL OF HYPERTENSION (2004)
An increase in the synthesis and release of calcitonin gene-related peptide in two-kidney, one-clip hypertensive rats
PY Deng et al.
REGULATORY PEPTIDES (2003)
Targeted disruption of adrenomedullin and αCGRP genes reveals their distinct biological roles
H Kurihara et al.
HYPERTENSION RESEARCH (2003)
Expression and regulation of calcitonin gene-related peptide receptor in rat placentas
YL Dong et al.
BIOLOGY OF REPRODUCTION (2002)
Production and secretion of calcitonin gene-related peptide from human lymphocytes
HC Wang et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
NGF modulates CGRP synthesis in human B-lymphocytes: a possible anti-inflammatory action of NGF?
L Bracci-Laudiero et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Characterization of calcitonin gene-related peptide (CGRP) receptors and their receptor-activity-modifying proteins (RAMPs), in human brain microvascular and astroglial cells in culture
MJ Moreno et al.
NEUROPHARMACOLOGY (2002)
Expression of vasoactive intestinal polypeptide and calcitonin gene-related peptide in human stellate ganglia after acute myocardial infarction
V Roudenok et al.
ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER (2001)
CGRP-RCP, a novel protein required for signal transduction at calcitonin gene-related peptide and adrenomedullin receptors
BN Evans et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks
M Ashina et al.
PAIN (2000)
CGRP and adrenomedullin binding correlates with transcript levels for Calcitonin Receptor-Like Receptor (CRLR) and Receptor Activity Modifying Proteins (RAMPs) in rat tissues
P Chakravarty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
H Doods et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
